Abstract
Hallmarks of asthma include chronic airway inflammation, progressive airway remodeling, and airway hyperresponsiveness. The initiation and perpetuation of these processes are attributable at least in part to critical events within the airway epithelium, but the underlying mechanisms remain poorly understood. New evidence now suggests that epithelial cells derived from donors without asthma versus donors with asthma, even in the absence of inflammatory cells or mediators, express modes of collective migration that innately differ not only in the amount of migration but also in the kind of migration. The maturing cell layer tends to undergo a transition from a hypermobile, fluid-like, unjammed phase in which cells readily rearrange, exchange places, and flow, to a quiescent, solid-like, jammed phase in which cells become virtually frozen in place. Moreover, the unjammed phase defines a phenotype that can be perpetuated by the compressive stresses caused by bronchospasm. Importantly, in cells derived from donors with asthma versus donors without asthma, this jamming transition becomes substantially delayed, thus suggesting an immature or dysmature epithelial phenotype in asthma.
Keywords: unjamming, cell mechanics, phase transition, bronchoconstriction
The lung routinely faces a variety of environmental stresses. With every breath, for example, irritants such as allergens, bacteria, viruses, or environmental pollutants can enter the lung (1, 2). These irritants trigger innate defense mechanisms, but these mechanisms can sometimes become dysregulated. Moreover, with every breath, the lung changes its size appreciably (3–5), and thereby stretches and distorts each of the lung’s multiple cellular constituents (6–8). Under normal physiological conditions, these mechanical stresses, in turn, are known to activate cellular signaling cascades (6, 9, 10) that guide branching morphogenesis and alveolar proliferation in utero and in early life (11, 12). For example, mechanical stress is upstream of the Hippo pathway that includes the activation of kinases, MST1/2 and LATS1/2, and the inactivation of cofactors YAP/TAZ (13). More interestingly, Varner and colleagues showed that a purely physical mechanism can control the pattern of the airway branching during embryonic lung development (14). But under certain pathologic conditions, such as during ventilator-induced lung injury or during bronchospasm, excessive mechanical stresses can impair normal lung function and cause aberrant airway repair after injury (4). Here we focus on mechanical stresses that arise spontaneously within the airway epithelium as a result of bronchospasm and the role these stresses play in airway remodeling in asthma.
How does mechanical stress impact airway epithelial cells? We now know that mechanical stress initiates the activation of signaling cascades and the release of fibrotic and inflammatory mediators (15–17). But as described below, compressive stress also causes mature airway epithelial cells to move in collective fluid-like swirls, whereas otherwise they are solid-like and virtually immobile. In this article, we discuss these phenomena in relation to the process of airway remodeling in asthma.
Activation of Epithelial Cells, Compressive Stress, and Bronchoconstriction
The transmural stress that distends the airway wall is supported by the outward tethering recoil of the lung parenchyma and is well approximated by the transpulmonary pressure (6, 18). During bronchoconstriction, however, the airway becomes compressed by the contraction of airway smooth muscle, and the airway epithelium then buckles into a rosette pattern (19). Finite-element modeling (20) shows that during maximal bronchoconstriction, airway smooth muscle can exert a compressive stress on the airway epithelial layer of approximately 30 cm H2O, which is much greater than the compressive stresses imposed on the epithelial layer during normal breathing or exercise.
Using rat tracheal epithelial cells maintained in air–liquid interface (ALI) culture, Ressler and colleagues showed that compressive stress causes rapid and robust epithelial cellular responses, including messenger RNA expression of early growth responsive protein 1, endothelin 1, and transforming growth factor β1 (21). Tschumperlin and colleagues then showed that primary human airway epithelial cells behave in a similar fashion, and suggested that associated squeezing of the lateral intercellular space (LIS) between epithelial cells, combined with shedding of epidermal growth factor into that space, leads to a novel mechanism of mechanotransduction (22). Using computational modeling, they concluded that the volume of the LIS changed maximally at 10 minutes after compression, at which time the concentration of heparin-binding epidermal growth factor (HB-EGF) in the LIS became readily increased (23). Subsequently, using a murine model, Shiomi and colleagues showed that activation of tumor necrosis factor α (TNF-α) converting enzyme is critical in the epidermal growth factor receptor (EGFR) activation response to compressive stress (24).
In bronchial epithelial cells, activation of EGFR and changes in EGFR-dependent transcriptomes are impacted by deformation of airway epithelial cells (25). The activation of EGFR results in the induction of the HB-EGF expression and phosphorylation of extracellular signal–regulated kinase (26). In the same cell, compared with responses elicited by exposure to TNF-α (1 ng/ml), the responsiveness of HB-EGF expression to compressive stress is similar. Mechanically activated EGFR initiates a positive feedback autocrine loop that involves the induction of EGFR ligands (27).
Together, these results establish that compressive mechanical stress mimicking bronchoconstriction initiates signal transduction pathways and provokes the production of asthma-associated mediators known to be implicated in airway remodeling.
Compressive Stress and Airway Remodeling
In asthmatic airways, airway epithelial cells display impaired proliferation of basal and club cells, together with exaggerated secretion of proinflammatory and profibrotic mediators and proteins, a reduced level of junctional proteins, and aberrant injury-repair responses (28–30). In cells from donors with asthma, there is evidence indicating higher levels of transforming growth factor β and granulocyte/macrophage colony-stimulating factor (31) in response to compressive stress, suggesting an exaggerated response of asthmatic cells to mechanical stress. In asthma, thickening of the subepithelium, which is composed of fibronectin and collagen types III and V, is a major remodeling event (32). Swartz and colleagues showed that the application of compressive stress significantly induces collagen type III production from fibroblasts that were conditioned with basolateral media collected from compressed normal human bronchial epithelial cells (15). In asthma, goblet-cell hyperplasia or metaplasia is also a major remodeling event (28, 33–36). Using primary normal human bronchial epithelial cells in ALI culture, Park and Tschumperlin showed that goblet-cell hyperplasia is induced by intermittent compressive stress (16). Under normal conditions, mucus produced from goblet cells protects the lung against inhaled irritants by trapping those irritants and then clearing them toward the airway opening through the action of the mucociliary escalator (37). With goblet cell hyperplasia or metaplasia, however, mucus hypersecretion can contribute to airway obstruction, which in turn is responsible for the morbidity and mortality that are associated with chronic airway diseases such as chronic obstructive pulmonary disease and asthma (38–42).
These in vitro studies suggested that airway remodeling can be induced independent of inflammatory cells, and these in vitro studies were later validated in humans in vivo (17); in patients with mild asthma, Grainge and colleagues (17) showed that repeated bronchoconstriction causes an increased number of goblet cells and a thickened subepithelium. As such, it is now clear that mechanical stress acting on the airway epithelium is sufficient by itself to induce a host of changes associated with the remodeled asthmatic airway.
Unanticipated Implications for Asthma Therapy
Even in the complete absence of augmented inflammatory cells or mediators, key phenotypic changes as observed in asthmatic airways can be induced by compressive mechanical stress alone (15–17). Could it be, therefore, that amelioration of bronchospasm might also attenuate remodeling events triggered by mechanotransduction pathways, and thus add to asthma treatment strategies in a dimension that was unanticipated previously? In that connection, numerous studies have shown that the combination of a long-acting β2-agonist (LABA) and an inhaled corticosteroid (ICS) is a far more effective treatment for asthma than high doses of ICS alone (43–45). For example, the combination of a low-dose ICS (budesonide) with a LABA (formoterol) has no more antiinflammatory effect than does a high-dose ICS (budesonide) alone (45). Similarly, post-treatment of allergen challenged individuals with asthma with LABA (formoterol) together with inhaled ICS (budesonide) reduces the number of myofibroblasts and the mass of airway smooth muscle compared with either treatment alone (46). The combination of LABA (salmeterol) with ICS (fluticasone propionate) also showed the greatest improvement in asthma endpoints, including the magnitude of change in morning peak expiratory flow, asthma symptoms, and rescue β2-agonist use, compared with ICS (fluticasone propionate) alone (47). Combination therapy can achieve better asthma control and a reduction of exacerbation risk and it is more effective in adults than in children (48).
Together, these findings suggest that LABA acting through its amelioration of bronchospasm may augment the antiinflammatory effect of ICS.
Jamming and Unjamming of Bronchial Epithelial Cells
Using primary human bronchial epithelial cells derived from donors without and with asthma and studies in ALI culture, Park and colleagues have recently established that a pseudostratified layer derived from donors without asthma is quiescent (49). Cellular motions are relatively small, cellular rearrangements among neighboring cells are rare, and each cell remains virtually caged by those immediate neighbors. Statistical analyses of these motions confirm that such a layer is solid-like and jammed. However, application of an apical-to-basal mechanical stress mimicking the compressive effect of bronchospasm (16, 17, 22) is sufficient to trigger large cellular motions and cooperative cellular rearrangements. Cells move chaotically, but the motions exhibit cooperative packs and swirls; such a layer is fluid-like and unjammed. When they examined the more complex process of progressive layer maturation, they found an innate tendency of the maturing layer to transition from an immature, fluid-like, unjammed phase in which cells readily rearrange and flow, into a mature, solid-like, jammed phase in which cells become virtually frozen in place (50–52). As compared with donors without asthma, however, in the maturing layer derived from donors with asthma this jamming transition is delayed substantially or disrupted altogether. Whether this delay arises from layer injury, immaturity, or dysmaturity remains unclear.
Where Do We Go from Here?
Open questions remain concerning unknown roles for mechanical stress in lung function and lung disease. The potential bronchoconstriction in the innate immune responses of the airway epithelial is particularly interesting because EGFR activation caused by viral infection suppresses the production of IFN-λ and CXCL-10, both of which are antiviral in the airway epithelium (53, 54). Although the mechanism remains unknown, compression of bronchial epithelial cells induces secretion of IL-8 (31), and compression of A549 cells activates nuclear factor-κB (55). These observations suggest that the innate immunity of the airway epithelial cells may be altered by bronchoconstriction itself. And as described above, the compressive stresses generated by bronchoconstriction are sufficient to induce cellular changes consistent with airway remodeling, even in the absence of inflammatory cells or mediators (15–17). Together, this evidence suggests that bronchoconstriction is not only a consequence of asthma progression and associated airway remodeling, but also a rather important contributor to these processes.
Footnotes
Author Contributions: J.-A.P. and J.J.F. wrote and revised the manuscript.
Author disclosures are available with the text of this article at www.atsjournals.org.
References
- 1.Fishman AP, Fisher AB.Pulmonay circulation. In: Geiger SR, editor. Handbook of physiology. The respiratory system. Circulation and nonrespiratory functions. Bethesda, Md.: American Physiological Society; 1985. pp. 93–166. [Google Scholar]
- 2.Mathieu-Nolf M. Poisons in the air: a cause of chronic disease in children. J Toxicol Clin Toxicol. 2002;40:483–491. doi: 10.1081/clt-120006751. [DOI] [PubMed] [Google Scholar]
- 3.Fleming S, Thompson M, Stevens R, Heneghan C, Plüddemann A, Maconochie I, Tarassenko L, Mant D. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet. 2011;377:1011–1018. doi: 10.1016/S0140-6736(10)62226-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369:2126–2136. doi: 10.1056/NEJMra1208707. [DOI] [PubMed] [Google Scholar]
- 5.Macklem PT. Respiratory mechanics. Annu Rev Physiol. 1978;40:157–184. doi: 10.1146/annurev.ph.40.030178.001105. [DOI] [PubMed] [Google Scholar]
- 6.Fredberg JJ, Kamm RD. Stress transmission in the lung: pathways from organ to molecule. Annu Rev Physiol. 2006;68:507–541. doi: 10.1146/annurev.physiol.68.072304.114110. [DOI] [PubMed] [Google Scholar]
- 7.Fredberg JJ, Bunk D, Ingenito E, Shore SA. Tissue resistance and the contractile state of lung parenchyma. J Appl Physiol (1985) 1993;74:1387–1397. doi: 10.1152/jappl.1993.74.3.1387. [DOI] [PubMed] [Google Scholar]
- 8.Yuan H, Ingenito EP, Suki B. Dynamic properties of lung parenchyma: mechanical contributions of fiber network and interstitial cells. J Appl Physiol (1985) 1997;83:1420–1431. doi: 10.1152/jappl.1997.83.5.1420. [DOI] [PubMed] [Google Scholar]
- 9.Plataki M, Hubmayr RD. The physical basis of ventilator-induced lung injury. Expert Rev Respir Med. 2010;4:373–385. doi: 10.1586/ers.10.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Orr AW, Helmke BP, Blackman BR, Schwartz MA. Mechanisms of mechanotransduction. Dev Cell. 2006;10:11–20. doi: 10.1016/j.devcel.2005.12.006. [DOI] [PubMed] [Google Scholar]
- 11.Schittny JC, Miserocchi G, Sparrow MP. Spontaneous peristaltic airway contractions propel lung liquid through the bronchial tree of intact and fetal lung explants. Am J Respir Cell Mol Biol. 2000;23:11–18. doi: 10.1165/ajrcmb.23.1.3926. [DOI] [PubMed] [Google Scholar]
- 12.Varner VD, Nelson CM. Cellular and physical mechanisms of branching morphogenesis. Development. 2014;141:2750–2759. doi: 10.1242/dev.104794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Saito A, Nagase T.Hippo and TGF-β interplay in the lung field Am J Physiol Lung Cell Mol Physiol (In press) [DOI] [PubMed]
- 14.Varner VD, Gleghorn JP, Miller E, Radisky DC, Nelson CM. Mechanically patterning the embryonic airway epithelium. Proc Natl Acad Sci USA. 2015;112:9230–9235. doi: 10.1073/pnas.1504102112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Swartz MA, Tschumperlin DJ, Kamm RD, Drazen JM. Mechanical stress is communicated between different cell types to elicit matrix remodeling. Proc Natl Acad Sci USA. 2001;98:6180–6185. doi: 10.1073/pnas.111133298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Park JA, Tschumperlin DJ. Chronic intermittent mechanical stress increases MUC5AC protein expression. Am J Respir Cell Mol Biol. 2009;41:459–466. doi: 10.1165/rcmb.2008-0195OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Grainge CL, Lau LC, Ward JA, Dulay V, Lahiff G, Wilson S, Holgate S, Davies DE, Howarth PH. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med. 2011;364:2006–2015. doi: 10.1056/NEJMoa1014350. [DOI] [PubMed] [Google Scholar]
- 18.Mead J, Takishima T, Leith D. Stress distribution in lungs: a model of pulmonary elasticity. J Appl Physiol. 1970;28:596–608. doi: 10.1152/jappl.1970.28.5.596. [DOI] [PubMed] [Google Scholar]
- 19.Yager D, Butler JP, Bastacky J, Israel E, Smith G, Drazen JM. Amplification of airway constriction due to liquid filling of airway interstices. J Appl Physiol (1985) 1989;66:2873–2884. doi: 10.1152/jappl.1989.66.6.2873. [DOI] [PubMed] [Google Scholar]
- 20.Wiggs BR, Hrousis CA, Drazen JM, Kamm RD. On the mechanism of mucosal folding in normal and asthmatic airways. J Appl Physiol (1985) 1997;83:1814–1821. doi: 10.1152/jappl.1997.83.6.1814. [DOI] [PubMed] [Google Scholar]
- 21.Ressler B, Lee RT, Randell SH, Drazen JM, Kamm RD. Molecular responses of rat tracheal epithelial cells to transmembrane pressure. Am J Physiol Lung Cell Mol Physiol. 2000;278:L1264–L1272. doi: 10.1152/ajplung.2000.278.6.L1264. [DOI] [PubMed] [Google Scholar]
- 22.Tschumperlin DJ, Dai G, Maly IV, Kikuchi T, Laiho LH, McVittie AK, Haley KJ, Lilly CM, So PT, Lauffenburger DA, et al. Mechanotransduction through growth-factor shedding into the extracellular space. Nature. 2004;429:83–86. doi: 10.1038/nature02543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Kojić N, Kojić M, Tschumperlin DJ. Computational modeling of extracellular mechanotransduction. Biophys J. 2006;90:4261–4270. doi: 10.1529/biophysj.105.078345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Shiomi T, Tschumperlin DJ, Park JA, Sunnarborg SW, Horiuchi K, Blobel CP, Drazen JM. TNF-α-converting enzyme/a disintegrin and metalloprotease-17 mediates mechanotransduction in murine tracheal epithelial cells. Am J Respir Cell Mol Biol. 2011;45:376–385. doi: 10.1165/rcmb.2010-0234OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kojic N, Chung E, Kho AT, Park JA, Huang A, So PT, Tschumperlin DJ. An EGFR autocrine loop encodes a slow-reacting but dominant mode of mechanotransduction in a polarized epithelium. FASEB J. 2010;24:1604–1615. doi: 10.1096/fj.09-145367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Tschumperlin DJ, Shively JD, Swartz MA, Silverman ES, Haley KJ, Raab G, Drazen JM. Bronchial epithelial compression regulates MAP kinase signaling and HB-EGF-like growth factor expression. Am J Physiol Lung Cell Mol Physiol. 2002;282:L904–L911. doi: 10.1152/ajplung.00270.2001. [DOI] [PubMed] [Google Scholar]
- 27.Chu EK, Foley JS, Cheng J, Patel AS, Drazen JM, Tschumperlin DJ. Bronchial epithelial compression regulates epidermal growth factor receptor family ligand expression in an autocrine manner. Am J Respir Cell Mol Biol. 2005;32:373–380. doi: 10.1165/rcmb.2004-0266OC. [DOI] [PubMed] [Google Scholar]
- 28.Lazaar AL, Panettieri RA., Jr Is airway remodeling clinically relevant in asthma? Am J Med. 2003;115:652–659. doi: 10.1016/j.amjmed.2003.07.010. [DOI] [PubMed] [Google Scholar]
- 29.Holgate ST. The sentinel role of the airway epithelium in asthma pathogenesis. Immunol Rev. 2011;242:205–219. doi: 10.1111/j.1600-065X.2011.01030.x. [DOI] [PubMed] [Google Scholar]
- 30.Lopez-Guisa JM, Powers C, File D, Cochrane E, Jimenez N, Debley JS. Airway epithelial cells from asthmatic children differentially express proremodeling factors. J Allergy Clin Immunol. 2012;129:990–997.e6. doi: 10.1016/j.jaci.2011.11.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Grainge C, Dennison P, Lau L, Davies D, Howarth P. Asthmatic and normal respiratory epithelial cells respond differently to mechanical apical stress. Am J Respir Crit Care Med. 2014;190:477–480. doi: 10.1164/rccm.201401-0107LE. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1989;1:520–524. doi: 10.1016/s0140-6736(89)90067-6. [DOI] [PubMed] [Google Scholar]
- 33.Homer RJ, Elias JA. Airway remodeling in asthma: therapeutic implications of mechanisms. Physiology (Bethesda) 2005;20:28–35. doi: 10.1152/physiol.00035.2004. [DOI] [PubMed] [Google Scholar]
- 34.Davies DE. The role of the epithelium in airway remodeling in asthma. Proc Am Thorac Soc. 2009;6:678–682. doi: 10.1513/pats.200907-067DP. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Halwani R, Al-Muhsen S, Hamid Q. Airway remodeling in asthma. Curr Opin Pharmacol. 2010;10:236–245. doi: 10.1016/j.coph.2010.06.004. [DOI] [PubMed] [Google Scholar]
- 36.Dunnill MS. The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol. 1960;13:27–33. doi: 10.1136/jcp.13.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest. 2002;109:571–577. doi: 10.1172/JCI15217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363:2233–2247. doi: 10.1056/NEJMra0910061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Cohn L. Mucus in chronic airway diseases: sorting out the sticky details. J Clin Invest. 2006;116:306–308. doi: 10.1172/JCI27690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Williams OW, Sharafkhaneh A, Kim V, Dickey BF, Evans CM. Airway mucus: from production to secretion. Am J Respir Cell Mol Biol. 2006;34:527–536. doi: 10.1165/rcmb.2005-0436SF. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Rubin BK, Priftis KN, Schmidt HJ, Henke MO. Secretory hyperresponsiveness and pulmonary mucus hypersecretion. Chest. 2014;146:496–507. doi: 10.1378/chest.13-2609. [DOI] [PubMed] [Google Scholar]
- 42.Curran DR, Cohn L. Advances in mucous cell metaplasia: a plug for mucus as a therapeutic focus in chronic airway disease. Am J Respir Cell Mol Biol. 2010;42:268–275. doi: 10.1165/rcmb.2009-0151TR. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Lalloo UG, Malolepszy J, Kozma D, Krofta K, Ankerst J, Johansen B, Thomson NC. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. Chest. 2003;123:1480–1487. doi: 10.1378/chest.123.5.1480. [DOI] [PubMed] [Google Scholar]
- 44.Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet. 1994;344:219–224. doi: 10.1016/s0140-6736(94)92996-3. [DOI] [PubMed] [Google Scholar]
- 45.Kips JC, O’Connor BJ, Inman MD, Svensson K, Pauwels RA, O’Byrne PM. A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma. Am J Respir Crit Care Med. 2000;161:996–1001. doi: 10.1164/ajrccm.161.3.9812056. [DOI] [PubMed] [Google Scholar]
- 46.Kelly MM, O'Connor TM, Leigh R, Otis J, Gwozd C, Gauvreau GM, Gauldie J, O'Byrne PM. Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma. J Allergy Clin Immunol. 2010;125:349–356. e313. doi: 10.1016/j.jaci.2009.09.011. [DOI] [PubMed] [Google Scholar]
- 47.Woodcock AA, Bagdonas A, Boonsawat W, Gibbs MR, Bousquet J, Bateman ED GOAL Steering Committee & Investigators. Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone. Prim Care Respir J. 2007;16:155–161. doi: 10.3132/pcrj.2007.00043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.O’Byrne PM, Parameswaran K. Pharmacological management of mild or moderate persistent asthma. Lancet. 2006;368:794–803. doi: 10.1016/S0140-6736(06)69289-1. [DOI] [PubMed] [Google Scholar]
- 49.Park JA, Kim JH, Bi D, Mitchell JA, Qazvini NT, Tantisira K, Park CY, McGill M, Kim SH, Gweon B, et al. Unjamming and cell shape in the asthmatic airway epithelium. Nat Mater. 2015;14:1040–1048. doi: 10.1038/nmat4357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Angelini TE, Hannezo E, Trepat X, Marquez M, Fredberg JJ, Weitz DA. Glass-like dynamics of collective cell migration. Proc Natl Acad Sci USA. 2011;108:4714–4719. doi: 10.1073/pnas.1010059108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Kim JH, Serra-Picamal X, Tambe DT, Zhou EH, Park CY, Sadati M, Park JA, Krishnan R, Gweon B, Millet E, et al. Propulsion and navigation within the advancing monolayer sheet. Nat Mater. 2013;12:856–863. doi: 10.1038/nmat3689. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Nnetu K, Knorr M, Pawlizak S, Fuhs TK.JA. Slow and anomalous dynamics of an MCF-10A epithelial cell monolayer Soft Matter 201399335–9341 [Google Scholar]
- 53.Ueki IF, Min-Oo G, Kalinowski A, Ballon-Landa E, Lanier LL, Nadel JA, Koff JL. Respiratory virus-induced EGFR activation suppresses IRF1-dependent interferon λ and antiviral defense in airway epithelium. J Exp Med. 2013;210:1929–1936. doi: 10.1084/jem.20121401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Kalinowski A, Ueki I, Min-Oo G, Ballon-Landa E, Knoff D, Galen B, Lanier LL, Nadel JA, Koff JL. EGFR activation suppresses respiratory virus-induced IRF1-dependent CXCL10 production. Am J Physiol Lung Cell Mol Physiol. 2014;307:L186–L196. doi: 10.1152/ajplung.00368.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Huang Y, Haas C, Ghadiali SN. Influence of transmural pressure and cytoskeletal structure on NF-κB activation in respiratory epithelial cells. Cell Mol Bioeng. 2010;3:415–427. doi: 10.1007/s12195-010-0138-7. [DOI] [PMC free article] [PubMed] [Google Scholar]